Cargando…

Association of antinuclear antibody seropositivity with inhaled environmental exposures in patients with interstitial lung disease

BACKGROUND: Interstitial lung diseases (ILDs) are diffuse parenchymal lung disorders that cause substantial morbidity and mortality. In patients with ILD, elevated antinuclear antibody (ANA) titres may be a sign of an autoimmune process. Inhalational exposures contribute to ILD pathogenesis and affe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biblowitz, Kathleen, Lee, Cathryn, Zhu, Daisy, Noth, Imre, Vij, Rekha, Strek, Mary E., Bellam, Shashi K., Adegunsoye, Ayodeji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573239/ https://www.ncbi.nlm.nih.gov/pubmed/34761002 http://dx.doi.org/10.1183/23120541.00254-2021

Ejemplares similares

N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia
por: Oldham, Justin M., et al.
Publicado: (2018)

High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease
por: Tyker, Albina, et al.
Publicado: (2021)

Automated CT Analysis of Major Forms of Interstitial Lung Disease
por: Crews, Marlee S., et al.
Publicado: (2020)

Interstitial Lung Disease in Firefighters: An Emerging Occupational Hazard
por: Lee, Cathryn T., et al.
Publicado: (2022)

Mortality Risk From COVID-19 Among Unvaccinated Subjects With Autoimmune Phenotypes of Interstitial Lung Disease
por: Strykowski, Rachel K, et al.
Publicado: (2022)

Autoimmune Hypothyroidism As a Predictor of Mortality in Chronic Hypersensitivity Pneumonitis
por: Adegunsoye, Ayodeji, et al.
Publicado: (2017)

Inhaled Nitric Oxide for Fibrotic Interstitial Lung Disease: A Step Forward
por: Khor, Yet H., et al.
Publicado: (2022)

Reply to Lescoat et al. and to Khamis et al.
por: Adegunsoye, Ayodeji, et al.
Publicado: (2019)

Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
por: Lee, Cathryn T., et al.
Publicado: (2022)

Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging
por: Chung, Jonathan H., et al.
Publicado: (2021)

Therapeutic Approach to Adult Fibrotic Lung Diseases
por: Adegunsoye, Ayodeji, et al.
Publicado: (2016)

Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease
por: Zhang, David, et al.
Publicado: (2023)

Antigenic responses are hallmarks of fibrotic interstitial lung diseases independent of underlying etiologies
por: Yoon, Young me, et al.
Publicado: (2023)

Skewed Lung CCR4 to CCR6 CD4(+) T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary Function
por: Adegunsoye, Ayodeji, et al.
Publicado: (2016)

Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis
por: Adegunsoye, Ayodeji, et al.
Publicado: (2017)

Helicobacter pylori seropositivity is associated with antinuclear antibodies in US adults, NHANES 1999–2000
por: Meier, H. C. S., et al.
Publicado: (2020)

The Bloom Is in Bud for Interstitial Lung Diseases
por: Noth, Imre, et al.
Publicado: (2020)

COVID-19 VACCINE UPTAKE IN AN INTERSTITIAL LUNG DISEASE CLINIC
por: LEAHY, AMY, et al.
Publicado: (2021)

Rituximab for interstitial pneumonia with autoimmune features at two medical centres
por: D’Silva, Kristin M, et al.
Publicado: (2021)

Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts
por: Adegunsoye, Ayodeji, et al.
Publicado: (2023)

Diagnostic test interpretation and referral delay in patients with interstitial lung disease
por: Pritchard, David, et al.
Publicado: (2019)

T cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survival
por: Bonham, Catherine A., et al.
Publicado: (2019)

Antinuclear Antibodies
por: Frank, David A.
Publicado: (1984)

Vulvar invasive squamous cell carcinoma in a young patient with Human Immunodeficiency Virus-seropositivity
por: Rao, T. S. Mohan, et al.
Publicado: (2015)

Occupational Exposures in Rheumatoid Arthritis-related Airway Disease: A Missing Link?
por: Lee, Cathryn T., et al.
Publicado: (2022)

ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s
por: Hrusch, Cara L., et al.
Publicado: (2017)

ANTINUCLEAR ANTIBODIES IN RABBIT ANTISERA
por: Barnett, Eugene V., et al.
Publicado: (1966)

Antinuclear antibodies in rosacea patients
por: Woźniacka, Anna, et al.
Publicado: (2013)

Guidelines for Antinuclear Antibody Testing
por: Wiik, Allan S.
Publicado: (2006)

Antinuclear antibodies in COVID 19
por: Muratori, Paolo, et al.
Publicado: (2021)

Hospitalizations in patients with idiopathic pulmonary fibrosis
por: Kim, Hyun J., et al.
Publicado: (2021)

Etiopathogenetic Mechanisms of Pulmonary Hypertension in Sleep-Related Breathing Disorders
por: Adegunsoye, Ayodeji, et al.
Publicado: (2012)

Inflammatory Response Mechanisms Exacerbating Hypoxemia in Coexistent Pulmonary Fibrosis and Sleep Apnea
por: Adegunsoye, Ayodeji, et al.
Publicado: (2015)

Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies
por: Strykowski, Rachel, et al.
Publicado: (2021)

A mathematical model of seropositivity to malaria antigen, allowing seropositivity to be prolonged by exposure
por: Bosomprah, Samuel
Publicado: (2014)

Mothers and the Mexican antinuclear power movement
por: García-Gorena, Velma
Publicado: (1999)

Antinuclear antibodies defining autoimmunity pathways
por: Tan, Eng M
Publicado: (2014)

The Prevalence of Antinuclear Antibodies in Patients with Sarcoidosis
por: Kobak, Senol, et al.
Publicado: (2014)

Antinuclear antibodies in autoimmune and allergic diseases
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2017)

Can Antinuclear Antibodies (ANA) be Monoclonal?
por: Biederman, Laura, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dl6sgpqafvb3ct9e7akdsh6hab